Acetyl-L-Carnitine and Alpha-Lipoic Acid: What the Research Shows

People stack acetyl-l-carnitine and alpha-lipoic acid together because both compounds feed mitochondrial energy production and support nerve tissue. The pair has been studied most often in diabetic peripheral neuropathy, male fertility, and age-related memory decline, but the evidence is modest and neither ingredient is FDA-approved to treat any condition. Typical daily intakes range from 500 mg to 2,000 mg of acetyl-L-carnitine (ALCAR) and 300 mg to 600 mg of alpha-lipoic acid (ALA), usually split into two servings.

What Each Supplement Does

Both are small molecules that the human body already handles in some form, which is one reason they are frequently sold in a single capsule.

Acetyl-L-carnitine (ALCAR)

Anyone trying to figure out what is acetyl l carnitine should know that it is the acetylated form of L-carnitine, an amino acid derivative that carries fatty acids into the mitochondria to be burned for energy. The acetyl group lets ALCAR cross the blood-brain barrier more easily than plain L-carnitine and supplies raw material for acetylcholine, a neurotransmitter involved in memory and muscle control.

Alpha-lipoic acid (ALA)

Alpha-lipoic acid is a sulfur-containing fatty acid that acts as a cofactor for mitochondrial enzymes and as an antioxidant that helps regenerate vitamins C and E and glutathione. Alpha-lipoic acid also supports glucose uptake into cells, which is why it appears so often in metabolic and nerve-related research.

Feature	Acetyl-L-carnitine (ALCAR)	Alpha-lipoic acid (ALA)
What it is	Acetylated form of the amino acid derivative L-carnitine	Sulfur-containing fatty acid the body makes in small amounts
Main role	Transports fatty acids into mitochondria; donates acetyl groups	Mitochondrial enzyme cofactor; recycles other antioxidants
Blood-brain barrier	Crosses readily	Crosses, but to a limited degree
Doses used in research	1,000-2,000 mg per day, sometimes up to 3,000 mg	600-1,800 mg per day
Regulatory status in the US	Dietary supplement; not FDA-approved for any disease	Dietary supplement; sold as a prescription drug in Germany

Why People Take Them Together

The two supplements are usually positioned as complementary rather than interchangeable.

• Energy plus antioxidant defense. ALCAR addresses the fuel side of mitochondrial function while ALA addresses oxidative stress and enzyme support.
• Nerve-focused research. Each has been tested on its own in diabetic neuropathy, and smaller studies have tested them as a pair.
• Convenience. A single capsule with both ingredients is easier to take than two separate bottles.

None of that makes the pair a proven treatment. Reviews of the combination repeatedly note small sample sizes and low study quality.

What the Research Actually Shows

Diabetic neuropathy

Alpha-lipoic acid has the strongest single-agent data. Intravenous ALA at 600 mg improved neuropathy symptoms in trials such as ALADIN and SYDNEY, and it is approved as a prescription drug for diabetic polyneuropathy in Germany. Oral ALA results have been more mixed, and acetyl-L-carnitine trials using 1,500 mg to 3,000 mg per day have reported reduced pain and modest gains in nerve conduction.

Studies that combine the two are fewer and smaller. Reviews describe the combination evidence as promising but weak, so it is reasonable to treat it as supportive rather than curative.

Cognitive function and aging

Older ALCAR trials in mild cognitive impairment and Alzheimer's disease showed some short-term gains on memory tests, while more recent reviews call the evidence insufficient. Alpha-lipoic acid has been studied in smaller cognitive trials with similarly mixed results.

Male fertility

Formulas containing L-carnitine, ALCAR, and ALA have improved sperm motility and density in some randomized trials of men with low sperm motility. Professional guidelines still do not recommend these supplements as a standard fertility treatment.

Typical Doses and Forms

Doses used in research are often higher than what a single capsule provides, so check whether amounts are listed per capsule or per serving.

Supplement	Common daily dose	How to take it	Notes
Acetyl-L-carnitine	500-2,000 mg, split into 2 doses	With food	Higher doses may cause restlessness or insomnia
Alpha-lipoic acid	300-600 mg, split into 2 doses	On an empty stomach, 30 minutes before a meal	Food reduces absorption; R-ALA is the active form
Combination products	Often 500 mg of each per serving	Follow the label, usually 2-3 capsules daily	Compare per-serving totals, not capsule counts

Labels may list the ingredient as acetyl l carnitine hcl, which is the hydrochloride salt form used to keep the powder stable. R-ALA is the biologically active form of alpha-lipoic acid, but most budget products contain a 50/50 mix of R-ALA and S-ALA.

Acetyl-L-Carnitine Side Effects and ALA Risks

Most acetyl l carnitine side effects are mild and digestive, including nausea, stomach cramps, and loose stools. Higher doses can trigger restlessness, agitation, or insomnia, especially when taken in the evening.

The most commonly reported side effects of acetyl-l-carnitine in clinical trials were nausea and vomiting, and they usually eased when the dose was lowered or the supplement was taken with food. Alpha-lipoic acid can cause similar stomach upset, plus headache and skin rash.

More serious concerns are worth knowing about:

• Blood sugar drops. Alpha-lipoic acid can lower blood glucose, so it may amplify insulin and other diabetes medications.
• Thyroid medication. Both ALA and carnitine can interfere with thyroid hormone action, so people taking levothyroxine should separate doses and check with their prescriber.
• Blood thinners. ALCAR has been reported to increase the effect of warfarin in some patients.
• Rare immune reaction. Alpha-lipoic acid has been linked to insulin autoimmune syndrome in genetically predisposed people, mostly in Japan.

Talk with a healthcare professional before starting either supplement, especially if you are pregnant, nursing, taking prescription medication, or managing a chronic condition. Supplements are not regulated like drugs in the United States, so potency and purity vary between brands.

How to Choose a Product

• Look for third-party testing seals such as USP, NSF Certified for Sport, or Informed Choice.
• Check the per-serving dose of each ingredient rather than the capsule count.
• Avoid "proprietary blend" labels that hide individual amounts.
• Pick a brand that names the exact form, such as acetyl-L-carnitine HCl or R-ALA.

Many combination products deliver only 250 mg to 500 mg of each ingredient per capsule, which means reaching research-level doses takes several capsules a day.

Bottom Line

Acetyl-L-carnitine and alpha-lipoic acid are two well-known mitochondrial supplements that are often paired for nerve and energy support. Neither acetyl-L-carnitine nor alpha-lipoic acid is FDA-approved to treat or prevent any disease in the United States. The best-quality evidence favors alpha-lipoic acid alone for diabetic neuropathy symptoms, while combination research remains small and preliminary. Standard doses are generally well tolerated, but blood sugar, thyroid, and blood-thinning interactions deserve attention before you start.

COMMON QUESTIONS

Frequently Asked Questions

Can you take acetyl-L-carnitine and alpha-lipoic acid together?

Yes. The two supplements are commonly sold in a single capsule and no major interaction between them has been reported in research. Start with a low dose, take ALA on an empty stomach and ALCAR with food, and check with a healthcare professional first if you take medication for diabetes, thyroid disease, or blood clotting.

What is a typical dose of acetyl-L-carnitine and alpha-lipoic acid?

Research doses generally range from 1,000 mg to 2,000 mg of acetyl-L-carnitine and 600 mg to 1,800 mg of alpha-lipoic acid per day, split into two servings. Over-the-counter products often supply less, around 500 mg of each per serving, so compare labels carefully before assuming you are getting a study-level dose.

Does alpha-lipoic acid help with diabetic neuropathy?

Intravenous alpha-lipoic acid at 600 mg improved neuropathy symptoms in several controlled trials, and it is approved as a prescription drug for diabetic polyneuropathy in Germany. Oral ALA results have been less consistent, and alpha-lipoic acid is not FDA-approved to treat neuropathy in the United States, so it should not replace standard medical care.